SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Marieke L. Nijland, Marie José Kersten, Steven T. Pals, Frederike J. Bemelman, Ineke J.M. ten Berge, Epstein-Barr Virus–Positive Posttransplant Lymphoproliferative Disease After Solid Organ Transplantation, Transplantation Direct, 2016, 2, 1, e48

    CrossRef

  2. 2
    Patrick Ho Yu Chung, See Ching Chan, Kwong Leung Chan, Yuk Sing Chan, Janette Siu Yin Kwok, Chung Mau Lo, Lowered Immune Cell Function in Liver Recipients Recovered From Posttransplant Lymphoproliferative Disease Who Developed Graft Tolerance, Transplantation Direct, 2016, 2, 3, e66

    CrossRef

  3. 3
    Muir Morton, Beatrice Coupes, James Ritchie, Stephen A. Roberts, Paul E. Klapper, Richard J. Byers, Pamela J. Vallely, Kate Ryan, Michael L. Picton, Post-transplant lymphoproliferative disorder in adult renal transplant recipients: survival and prognosis, Leukemia & Lymphoma, 2016, 57, 2, 299

    CrossRef

  4. 4
    S. Arze, L. Arze, C. Abecia, Post-transplantation Infections in Bolivia, Transplantation Proceedings, 2016, 48, 2, 646

    CrossRef

  5. 5
    D. Dierickx, T. Tousseyn, O. Gheysens, How I treat posttransplant lymphoproliferative disorders, Blood, 2015, 126, 20, 2274

    CrossRef

  6. 6
    Anjana A. Pillai, Management of de novo malignancies after liver transplantation, Transplantation Reviews, 2015, 29, 1, 38

    CrossRef

  7. 7
    Augusto Lauro, Mario Arpinati, Antonio D. Pinna, Managing the challenge of PTLD in liver and bowel transplant recipients, British Journal of Haematology, 2015, 169, 2
  8. 8
    J. Rossignol, L. Terriou, D. Robu, C. Willekens, B. Hivert, L. Pascal, R. Guieze, R. Trappe, C. Baillet, D. Huglo, F. Morschhauser, Radioimmunotherapy (90Y-Ibritumomab Tiuxetan) for Posttransplant Lymphoproliferative Disorders After Prior Exposure to Rituximab, American Journal of Transplantation, 2015, 15, 7
  9. 9
    M. R. Luskin, D. S. Heil, K. S. Tan, S. Choi, E. A. Stadtmauer, S. J. Schuster, D. L. Porter, R. H. Vonderheide, A. Bagg, D. F. Heitjan, D. E. Tsai, R. Reshef, The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder, American Journal of Transplantation, 2015, 15, 10
  10. 10
    Fernando Pardo, José Antonio Pons, Javier Briceño, V Consensus Meeting of the Spanish Society for Liver Transplant on High-Risk Recipients, Immunosupression Scenarios and Management of Hepatocarcinoma on the Transplant Waiting List, Cirugía Española (English Edition), 2015, 93, 10, 619

    CrossRef

  11. 11
    Fernando Pardo, José Antonio Pons, Javier Briceño, V Reunión de Consenso de la Sociedad Española de Trasplante Hepático sobre receptores de riesgo elevado, escenarios actuales de inmunosupresión y manejo del hepatocarcinoma en espera de trasplante, Cirugía Española, 2015, 93, 10, 619

    CrossRef

  12. 12
    Fernando Pardo, José Antonio Pons, Javier Briceño, V Reunión de Consenso de la Sociedad Española de Trasplante Hepático sobre receptores de riesgo elevado, escenarios actuales de inmunosupresión y manejo del hepatocarcinoma en espera de trasplante, Gastroenterología y Hepatología, 2015, 38, 10, 600

    CrossRef

  13. 13
    Juan F. Gallegos-Orozco, Jeffrey Campsen, Transplantation of the Liver, 2015,

    CrossRef

  14. 14
    Amelie Kinch, Eva Baecklund, Carin Backlin, Tor Ekman, Daniel Molin, Gunnar Tufveson, Pia Fernberg, Christer Sundström, Karlis Pauksens, Gunilla Enblad, A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival, Acta Oncologica, 2014, 53, 5, 669

    CrossRef

  15. 15
    Nolwenn Rabot, Matthias Büchler, Yohann Foucher, Anne Moreau, Celine Debiais, Marie-Christine Machet, Michelle Kessler, Emmanuel Morelon, Antoine Thierry, Christophe Legendre, Joseph Rivalan, Nassim Kamar, Jacques Dantal, CNI withdrawal for post-transplant lymphoproliferative disorders in kidney transplant is an independent risk factor for graft failure and mortality, Transplant International, 2014, 27, 9
  16. 16
    Daniel J Dorgan, Denis Hadjiliadis, Lung transplantation in patients with cystic fibrosis: special focus to infection and comorbidities, Expert Review of Respiratory Medicine, 2014, 8, 3, 315

    CrossRef

  17. 17
    Jean-Emmanuel Serre, David Michonneau, Emmanuel Bachy, Laure-Hélène Noël, Valérie Dubois, Caroline Suberbielle, Henri Kreis, Christophe Legendre, Marie-France Mamzer-Bruneel, Emmanuel Morelon, Olivier Thaunat, Maintaining calcineurin inhibition after the diagnosis of post-transplant lymphoproliferative disorder improves renal graft survival, Kidney International, 2014, 85, 1, 182

    CrossRef

  18. 18
    H.P. Cathro, G.C. Bullock, H. Bonatti, Z. Meriden, S. Cook, N. Aguilera, Post-transplant lymphoproliferative disorders are not associated with IgG4 sclerosing disease, Transplant Infectious Disease, 2014, 16, 6
  19. 19
    Nikolai Podoltsev, Bingnan Zhang, Xiaopan Yao, Ivan Bustillo, Yanhong Deng, Dennis L. Cooper, Chemoimmunotherapy and Withdrawal of Immunosupression for Monomorphic Posttransplant Lymphoproliferative Disorders, Clinical Lymphoma Myeloma and Leukemia, 2013, 13, 6, 716

    CrossRef

  20. 20
    G. Mourad, C. Alméras, S. Delmas, V. Garrigue, V. Pernin, I. Szwarc, F. Vetromile, Complications infectieuses et néoplasiques après transplantation rénale, EMC - Néphrologie, 2013, 10, 1, 1

    CrossRef

  21. 21
    R. Na, A. E. Grulich, N. S. Meagher, G. W. McCaughan, A. M. Keogh, C. M. Vajdic, De novo Cancer-Related Death in Australian Liver and Cardiothoracic Transplant Recipients, American Journal of Transplantation, 2013, 13, 5
  22. 22
    H. Zimmermann, R. U. Trappe, EBV and posttransplantation lymphoproliferative disease: what to do?, Hematology, 2013, 2013, 1, 95

    CrossRef

  23. 23
    U. D. Allen, J. K. Preiksaitis, Epstein-Barr Virus and Posttransplant Lymphoproliferative Disorder in Solid Organ Transplantation, American Journal of Transplantation, 2013, 13, s4
  24. 24
    M. Green, M. G. Michaels, Epstein–Barr Virus Infection and Posttransplant Lymphoproliferative Disorder, American Journal of Transplantation, 2013, 13, s3
  25. 25
    Deirdre A. Kelly, John C. Bucuvalas, Estella M. Alonso, Saul J. Karpen, Upton Allen, Michael Green, Douglas Farmer, Eyal Shemesh, Ruth A. McDonald, Long-term medical management of the pediatric patient after liver transplantation: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation, Liver Transplantation, 2013, 19, 8
  26. 26
    S. Hartmann, M.L. Hansmann, Lymphknotenpathologie – ein Update, Der Pathologe, 2013, 34, 1, 34

    CrossRef

  27. 27
    Meghan Karuturi, Nirav Shah, Dale Frank, Omotayo Fasan, Ran Reshef, Vivek N. Ahya, Michael Bromberg, Thomas Faust, Simin Goral, Stephen J. Schuster, Edward A. Stadtmauer, Donald E. Tsai, Plasmacytic post-transplant lymphoproliferative disorder: a case series of nine patients, Transplant International, 2013, 26, 6
  28. 28
    Zeina Al-Mansour, Beverly P. Nelson, Andrew M. Evens, Post-Transplant Lymphoproliferative Disease (PTLD): Risk Factors, Diagnosis, and Current Treatment Strategies, Current Hematologic Malignancy Reports, 2013, 8, 3, 173

    CrossRef

  29. 29
    Birte Wistinghausen, Thomas G. Gross, Catherine Bollard, Post-Transplant Lymphoproliferative Disease in Pediatric Solid Organ Transplant Recipients, Pediatric Hematology and Oncology, 2013, 30, 6, 520

    CrossRef

  30. 30
    Esther Ramos, Francisco Hernández, Ane Andres, Eva Martínez-Ojinaga, Manuel Molina, Jesús Sarría, Manuel Lopez-Santamaria, Gerardo Prieto, Post-transplant lymphoproliferative disorders and other malignancies after pediatric intestinal transplantation: Incidence, clinical features and outcome, Pediatric Transplantation, 2013, 17, 5
  31. 31
    Eli Muchtar, Mordechai R. Kramer, Liat Vidal, Ron Ram, Ronit Gurion, Yivgenia Rosenblat, Ilana Bakal, Ofer Shpilberg, Posttransplantation Lymphoproliferative Disorder in Lung Transplant Recipients, Transplantation Journal, 2013, 96, 7, 657

    CrossRef

  32. 32
    A. M. Evens, S. Choquet, A. R. Kroll-Desrosiers, D. Jagadeesh, S. M. Smith, F. Morschhauser, V. Leblond, R. Roy, B. Barton, L. I. Gordon, M. K. Gandhi, D. Dierickx, D. Schiff, T. M. Habermann, R. Trappe, Primary CNS Posttransplant Lymphoproliferative Disease (PTLD): An International Report of 84 Cases in the Modern Era, American Journal of Transplantation, 2013, 13, 6
  33. 33
    A. M. Evens, S. Choquet, A. R. Kroll-Desrosiers, D. Jagadeesh, S. M. Smith, F. Morschhauser, V. Leblond, R. Roy, B. Barton, L. I. Gordon, M. K. Gandhi, D. Dierickx, D. Schiff, T. M. Habermann, R. Trappe, Primary CNS Posttransplant Lymphoproliferative Disease (PTLD): An International Report of 84 Cases in the Modern Era, American Journal of Transplantation, 2013, n/a

    CrossRef

  34. 34
    Daan Dierickx, Thomas Tousseyn, Xavier Sagaert, Steffen Fieuws, Iwona Wlodarska, Julie Morscio, Lieselot Brepoels, Dirk Kuypers, Johan Vanhaecke, Frederik Nevens, Geert Verleden, Rita Van Damme-Lombaerts, Marleen Renard, Jacques Pirenne, Christiane De Wolf-Peeters, Gregor Verhoef, Single-center analysis of biopsy-confirmed posttransplant lymphoproliferative disorder: incidence, clinicopathological characteristics and prognostic factors, Leukemia & Lymphoma, 2013, 54, 11, 2433

    CrossRef

  35. 35
    Natasha Chandok, Kymberly D. Watt, Burden of de novo malignancy in the liver transplant recipient, Liver Transplantation, 2012, 18, 11
  36. 36
    Heiner Zimmermann, Petra Reinke, Ruth Neuhaus, Hans Lehmkuhl, Stephan Oertel, Johannes Atta, Manfred Planker, Barbara Gärtner, Dido Lenze, Ioannis Anagnostopoulos, Hanno Riess, Ralf U. Trappe, Burkitt post-transplantation lymphoma in adult solid organ transplant recipients, Cancer, 2012, 118, 19
  37. 37
    T. G. Gross, M. A. Orjuela, S. L. Perkins, J. R. Park, J. C. Lynch, M. S. Cairo, L. M. Smith, R. J. Hayashi, Low-Dose Chemotherapy and Rituximab for Posttransplant Lymphoproliferative Disease (PTLD): A Children's Oncology Group Report, American Journal of Transplantation, 2012, 12, 11
  38. 38
    A. Viardot, Maligne Lymphome: Klinik, Klassifikation, Therapie und Prognose, Der Radiologe, 2012, 52, 4, 321

    CrossRef

  39. 39
    Josep M. Campistol, Valentín Cuervas-Mons, Nicolás Manito, Luis Almenar, Manuel Arias, Fernando Casafont, Domingo del Castillo, María G. Crespo-Leiro, Juan F. Delgado, J. Ignacio Herrero, Paloma Jara, José M. Morales, Mercedes Navarro, Federico Oppenheimer, Martín Prieto, Luis A. Pulpón, Antoni Rimola, Antonio Román, Daniel Serón, Piedad Ussetti, New concepts and best practices for management of pre- and post-transplantation cancer, Transplantation Reviews, 2012, 26, 4, 261

    CrossRef

  40. 40
    Heiner Zimmermann, Ilske Oschlies, Susanne Fink, Christiane Pott, Hans H. Neumayer, Hans Lehmkuhl, Ingeborg A. Hauser, Martin Dreyling, Michael Kneba, Barbara Gärtner, Ioannis Anagnostopoulos, Hanno Riess, Wolfram Klapper, Ralf U. Trappe, Plasmablastic Posttransplant Lymphoma, Transplantation, 2012, 93, 5, 543

    CrossRef

  41. 41
    Deepa Jagadeesh, Bruce A. Woda, Jacqueline Draper, Andrew M. Evens, Post Transplant Lymphoproliferative Disorders: Risk, Classification, and Therapeutic Recommendations, Current Treatment Options in Oncology, 2012, 13, 1, 122

    CrossRef

  42. 42
    Brandon E. Kremer, Ran Reshef, Jamal G. Misleh, Jason D. Christie, Vivek N. Ahya, Nancy P. Blumenthal, Robert M. Kotloff, Denis Hadjiliadis, Edward A. Stadtmauer, Stephen J. Schuster, Donald E. Tsai, Post-transplant lymphoproliferative disorder after lung transplantation: A review of 35 cases, The Journal of Heart and Lung Transplantation, 2012, 31, 3, 296

    CrossRef

  43. 43
    Ralf Trappe, Stephan Oertel, Veronique Leblond, Peter Mollee, Monica Sender, Petra Reinke, Ruth Neuhaus, Hans Lehmkuhl, Heinz August Horst, Gilles Salles, Franck Morschhauser, Arnaud Jaccard, Thierry Lamy, Malte Leithäuser, Heiner Zimmermann, Ioannis Anagnostopoulos, Martine Raphael, Hanno Riess, Sylvain Choquet, Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial, The Lancet Oncology, 2012, 13, 2, 196

    CrossRef

  44. 44
    Ruy J. Cruz, Sumana Ramachandra, Eisaburo Sasatomi, Andrea DiMartini, Michael de Vera, Paulo Fontes, Christopher Hughes, Abhinav Humar, Surgical Management of Gastrointestinal Posttransplant Lymphoproliferative Disorders in Liver Transplant Recipients, Transplantation Journal, 2012, 94, 4, 417

    CrossRef

  45. 45
    Michael Green, Steven A. Webber, Post-Transplant Lymphoproliferative Disorders,